{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T11:39:04Z","timestamp":1772278744429,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.nefroe.2026.501426","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:54:05Z","timestamp":1770929645000},"page":"501426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of iptacopan in idiopathic immune complex\u2013mediated membranoproliferative glomerulonephritis refractory to conventional treatment"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8557-3145","authenticated-orcid":false,"given":"Raquel","family":"L\u00f3pez Hidalgo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Caba Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Ruiz Escolano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Delgado S\u00e1nchez de Murga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Fern\u00e1ndez Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jos\u00e9","family":"Espigares Huete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2026.501426_bib0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ndt\/gfad182","article-title":"C3G and Ig-MPGN\u2014treatment standard","volume":"39","author":"Noris","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2026.501426_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ndt\/gfab281","article-title":"Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment","volume":"38","author":"Noris","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2026.501426_bib0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.kint.2020.05.053","article-title":"Practical management of C3 glomerulopathy and ig-mediated MPGN: facts and uncertainties","volume":"98","author":"Fakhouri","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2026.501426_bib0020","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/ndt\/gfab302","article-title":"C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies","volume":"37","author":"Caravaca-Font\u00e1n","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2026.501426_bib0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ckj\/sfz178","article-title":"Direct-acting antiviral therapy improves kidney survival in hepatitis C virus-associated cryoglobulinaemia: the RENALCRYOGLOBULINEMIC study","volume":"14","author":"P\u00e9rez de Jos\u00e9","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2026.501426_bib0030","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00467-020-04736-8","article-title":"Therapy and outcomes of C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis","volume":"36","author":"Khandelwal","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2026.501426_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2180508","article-title":"Rituximab for treatment of membranoproliferative glomerulonephritis and C3 glomerulopathies","volume":"2017","author":"Rudnicki","year":"2017","journal-title":"Biomed Res Int"},{"issue":"4S","key":"10.1016\/j.nefroe.2026.501426_bib0040","first-page":"S1","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2026.501426_bib0045","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1073\/pnas.1820892116","article-title":"Small-molecule factor B inhibitor for the treatment of complement- mediated diseases","volume":"116","author":"Schubart","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nefroe.2026.501426_bib0050","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00467-009-1322-7","article-title":"Membranoproliferative glomerulonephritis","volume":"25","author":"Alchi","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2026.501426_bib0055","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2215\/CJN.16801221","article-title":"Association of histologic parameters with outcome in C3 glomerulopathy and idiopathic immunoglobulin-associated membranoproliferative glomerulonephritis","volume":"17","author":"Lomax-Browne","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"S1","key":"10.1016\/j.nefroe.2026.501426_bib0060","first-page":"56","article-title":"Iptacop\u00e1n, un nuevo inhibidor oral del factor B del complemento, reduce significativamente la proteinuria y los dep\u00f3sitos de C3 en ri\u00f1ones nativos y trasplantados con glomerulopat\u00eda C3","volume":"42","author":"Praga","year":"2022","journal-title":"Rev Nefrologia"},{"key":"10.1016\/j.nefroe.2026.501426_bib0065","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1016\/j.ekir.2023.02.610","article-title":"WCN23-0403 an open-label, non-randomized extension study to evaluate long-term efficacy, safety, and tolerability of Lnp023 in subjects with C3 glomerulopathy: interim analysis of phase 2 study","volume":"8","author":"Nester","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.nefroe.2026.501426_bib0070","first-page":"S618","article-title":"Update to the long-term safety and efficacy of iptacopan in C3G: 33-month extension study data from patients enrolled in a Phase 2, study","volume":"10","author":"Nester","year":"2025","journal-title":"ISN. [Internet]"},{"key":"10.1016\/j.nefroe.2026.501426_bib0075","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.ekir.2022.07.004","article-title":"Alternative complement pathway inhibition with iptacopan for the treatment of C3 glomerulopathy-study design of the APPEAR-C3G trial","volume":"7","author":"Bomback","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"10S","key":"10.1016\/j.nefroe.2026.501426_bib0080","article-title":"Efficacy and safety of iptacopan in patients with C3 glomerulopathy: 12-month results from the phase 3, APPEAR-C3G study","volume":"35","author":"Nester","year":"2024","journal-title":"JASN. [Internet]"},{"key":"10.1016\/j.nefroe.2026.501426_bib0085","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/j.ekir.2023.02.619","article-title":"WCN23-0584 A multicenter, randomized, double-blind, placebo- controlled phase 3 study to assess the efficacy and safety of Iptacopan in idiopathic immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN)","volume":"8","author":"Veldandi","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"10S","key":"10.1016\/j.nefroe.2026.501426_bib0090","volume":"35","author":"Nester","year":"2024","journal-title":"JASN"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T08:17:17Z","timestamp":1772266637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251426000234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2013251426000234"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501426","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of iptacopan in idiopathic immune complex\u2013mediated membranoproliferative glomerulonephritis refractory to conventional treatment","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2025.501426","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501426"}}